411 related articles for article (PubMed ID: 15790738)
21. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
Takami M; Takahashi N; Udagawa N; Miyaura C; Suda K; Woo JT; Martin TJ; Nagai K; Suda T
Endocrinology; 2000 Dec; 141(12):4711-9. PubMed ID: 11108286
[TBL] [Abstract][Full Text] [Related]
22. Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2004 Jan; 33(1):46-52. PubMed ID: 14675140
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption.
Wise GE; Yao S; Zhang Q; Ren Y
Arch Oral Biol; 2002 Mar; 47(3):247-54. PubMed ID: 11839361
[TBL] [Abstract][Full Text] [Related]
24. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice.
Oshiro T; Shiotani A; Shibasaki Y; Sasaki T
Anat Rec; 2002 Apr; 266(4):218-25. PubMed ID: 11920384
[TBL] [Abstract][Full Text] [Related]
25. Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro.
Hasegawa T; Kikuiri T; Takeyama S; Yoshimura Y; Mitome M; Oguchi H; Shirakawa T
Tissue Cell; 2002 Feb; 34(1):44-51. PubMed ID: 11989970
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
[TBL] [Abstract][Full Text] [Related]
27. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
28. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
[TBL] [Abstract][Full Text] [Related]
30. P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.
Tao H; Okamoto M; Nishikawa M; Yoshikawa H; Myoui A
PLoS One; 2011; 6(8):e23199. PubMed ID: 21886782
[TBL] [Abstract][Full Text] [Related]
31. Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells.
Nukaga J; Kobayashi M; Shinki T; Song H; Takada T; Takiguchi T; Kamijo R; Hasegawa K
J Periodontol; 2004 Feb; 75(2):249-59. PubMed ID: 15068113
[TBL] [Abstract][Full Text] [Related]
32. CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway.
Villa I; Mrak E; Rubinacci A; Ravasi F; Guidobono F
Am J Physiol Cell Physiol; 2006 Sep; 291(3):C529-37. PubMed ID: 16611736
[TBL] [Abstract][Full Text] [Related]
33. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation.
Karst M; Gorny G; Galvin RJ; Oursler MJ
J Cell Physiol; 2004 Jul; 200(1):99-106. PubMed ID: 15137062
[TBL] [Abstract][Full Text] [Related]
34. CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption.
Heinrich J; Bsoul S; Barnes J; Woodruff K; Abboud S
Arch Oral Biol; 2005 Oct; 50(10):897-908. PubMed ID: 16137499
[TBL] [Abstract][Full Text] [Related]
35. Vector-averaged gravity regulates gene expression of receptor activator of NF-kappaB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway.
Kanematsu M; Yoshimura K; Takaoki M; Sato A
Bone; 2002 Apr; 30(4):553-8. PubMed ID: 11934645
[TBL] [Abstract][Full Text] [Related]
36. Osteoclastogenesis during mouse tooth germ development is mediated by receptor activator of NFKappa-B ligand (RANKL).
Suzuki T; Suda N; Ohyama K
J Bone Miner Metab; 2004; 22(3):185-91. PubMed ID: 15108059
[TBL] [Abstract][Full Text] [Related]
37. The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha,25-dihydroxyvitamin D3.
Zhang D; Yang YQ; Li XT; Fu MK
Arch Oral Biol; 2004 Jan; 49(1):71-6. PubMed ID: 14693199
[TBL] [Abstract][Full Text] [Related]
38. High extracellular calcium affects osteoclastogenesis in mouse bone marrow cell culture.
Takahashi E; Mukohyama H; Aoki K; Duarte WR; Lerner UH; Ohya K; Omura K; Kasugai S
J Med Dent Sci; 2002 Dec; 49(4):109-20. PubMed ID: 12641381
[TBL] [Abstract][Full Text] [Related]
39. PTHrP induces Notch signaling in periodontal ligament cells.
Nakao A; Kajiya H; Fukushima H; Fukushima A; Anan H; Ozeki S; Okabe K
J Dent Res; 2009 Jun; 88(6):551-6. PubMed ID: 19587161
[TBL] [Abstract][Full Text] [Related]
40. Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells.
Notoya M; Otsuka E; Yamaguchi A; Hagiwara H
Biochem Biophys Res Commun; 2004 Nov; 324(2):655-60. PubMed ID: 15474477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]